Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-07-05 Sale |
2022-07-07 4:06 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
26,105 | $30.11 | $785,913 | 333,349 (Direct) |
View |
| 2022-04-13 Sale |
2022-04-15 4:19 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
45,000 | $34.65 | $1,559,093 | 192,855 (Direct) |
View |
| 2022-03-29 Sale |
2022-03-31 4:05 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
10,000 | $35 | $350,000 | 237,855 (Direct) |
View |
| 2022-03-16 Sale |
2022-03-18 7:56 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
45,000 | $31.11 | $1,400,009 | 513,730 (Direct) |
View |
| 2022-03-09 Sale |
2022-03-11 4:08 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
30,000 | $33.33 | $1,000,000 | 292,855 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-04 4:12 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
25,000 | $30 | $750,000 | 322,855 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 6:46 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
25,000 | $30 | $750,000 | 516,711 (Direct) |
View |
| 2021-12-23 Sale |
2021-12-28 4:31 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
10,000 | $35 | $350,027 | 747,857 (Direct) |
View |
| 2021-12-21 Sale |
2021-12-23 5:14 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
7,300 | $32.5 | $237,250 | 382,855 (Direct) |
View |
| 2021-12-15 Sale |
2021-12-17 8:27 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
37,700 | $30.85 | $1,163,198 | 1,186,327 (Direct) |
View |
| 2021-11-10 Sale |
2021-11-15 4:18 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
55,000 | $39.86 | $2,192,187 | 425,875 (Direct) |
View |
| 2021-08-26 Purchase |
2021-08-31 2:15 pm |
Cerevel Therapeutics Holdings Inc. | CERE | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director |
68,047 | $30.23 | $2,057,061 | 5,086,727 (Indirect) |
View |
| 2021-08-23 Purchase |
2021-08-25 7:14 pm |
Cerevel Therapeutics Holdings Inc. | CERE | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director |
175,585 | $27.53 | $4,833,885 | 5,018,680 (Indirect) |
View |
| 2021-07-07 Purchase |
2021-07-09 6:39 pm |
Cerevel Therapeutics Holdings Inc. | CERE | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director |
200,000 | $25 | $5,000,000 | 4,843,095 (Indirect) |
View |
| 2021-06-17 Purchase |
2021-06-22 6:31 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Sulzberger Gabrielle Director |
21,084 | $13.06 | $275,357 | 35,354 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-07-05 Exercise |
2022-07-07 4:06 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
26,105 | $3.5 | 333,349 (Direct) |
View |
| 2022-07-05 Exercise |
2022-07-07 4:06 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
26,105 | $0 | 333,349 (Direct) |
View |
| 2022-06-24 Exercise |
2022-06-28 4:14 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Sulzberger Gabrielle Director |
14,270 | $0 | 63,894 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 5:11 pm |
N/A 2032-06-14 |
Cerevel Therapeutics Holdings Inc. | CERE | Gordon Christopher R Director 10% Owner |
23,459 | $0 | 23,459 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 5:10 pm |
N/A 2032-06-14 |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
23,459 | $0 | 23,459 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:49 pm |
N/A 2032-06-14 |
Cerevel Therapeutics Holdings Inc. | CERE | Mckernan Ruth Director |
23,459 | $0 | 23,459 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:49 pm |
N/A 2032-06-14 |
Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director |
23,459 | $0 | 23,459 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:46 pm |
N/A 2032-06-14 |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
23,459 | $0 | 23,459 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:46 pm |
N/A 2032-06-14 |
Cerevel Therapeutics Holdings Inc. | CERE | Giordano Douglas E. Director |
23,459 | $0 | 23,459 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:46 pm |
N/A 2032-06-14 |
Cerevel Therapeutics Holdings Inc. | CERE | PATRICK DEVAL L Director |
23,459 | $0 | 23,459 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:41 pm |
N/A 2032-06-14 |
Cerevel Therapeutics Holdings Inc. | CERE | Sulzberger Gabrielle Director |
23,459 | $0 | 23,459 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:45 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Bodenrader Mark See Remarks |
18,932 | $0 | 18,932 (Direct) |
View |
| 2022-04-13 Exercise |
2022-04-15 4:19 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
45,000 | $3.5 | 192,855 (Direct) |
View |
| 2022-04-13 Exercise |
2022-04-15 4:19 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
45,000 | $0 | 192,855 (Direct) |
View |
| 2022-03-31 Other |
2022-04-04 4:26 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | PF Equity Holdings 1 B.V. 10% Owner |
27,349,211 | $0 | 27,349,211 (Direct) |
View |
| 2022-03-29 Exercise |
2022-03-31 4:05 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
10,000 | $3.5 | 237,855 (Direct) |
View |
| 2022-03-29 Exercise |
2022-03-31 4:05 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
10,000 | $0 | 237,855 (Direct) |
View |
| 2022-03-16 Exercise |
2022-03-18 7:56 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
45,000 | $3.5 | 513,730 (Direct) |
View |
| 2022-03-16 Exercise |
2022-03-18 7:56 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
45,000 | $0 | 513,730 (Direct) |
View |
| 2022-03-09 Exercise |
2022-03-11 4:08 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
30,000 | $3.5 | 292,855 (Direct) |
View |
| 2022-03-09 Exercise |
2022-03-11 4:08 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
30,000 | $0 | 292,855 (Direct) |
View |
| 2022-03-02 Exercise |
2022-03-04 4:12 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
25,000 | $3.5 | 322,855 (Direct) |
View |
| 2022-03-02 Exercise |
2022-03-04 4:12 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
25,000 | $0 | 322,855 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:47 pm |
N/A 2032-02-09 |
Cerevel Therapeutics Holdings Inc. | CERE | Bodenrader Mark See Remarks |
24,800 | $0 | 24,800 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:46 pm |
N/A 2032-02-09 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
168,856 | $0 | 516,711 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-11 6:46 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
25,000 | $3.5 | 516,711 (Direct) |
View |
| 2022-02-09 Exercise |
2022-02-11 6:46 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
25,000 | $0 | 516,711 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:46 pm |
N/A 2032-02-09 |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
120,310 | $0 | 120,310 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:45 pm |
N/A 2032-02-09 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
425,772 | $0 | 425,772 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:43 pm |
N/A 2032-02-09 |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
168,856 | $0 | 168,856 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:43 pm |
N/A 2032-02-09 |
Cerevel Therapeutics Holdings Inc. | CERE | Akamine Scott Chief Legal Officer |
58,572 | $0 | 58,572 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:42 pm |
N/A 2032-02-09 |
Cerevel Therapeutics Holdings Inc. | CERE | DiPietro Kenneth Chief Human Resources Officer |
75,985 | $0 | 75,985 (Direct) |
View |
| 2022-02-09 Option Award |
2022-02-11 6:39 pm |
N/A 2032-02-09 |
Cerevel Therapeutics Holdings Inc. | CERE | Tregoning Kathleen See Remarks |
63,321 | $0 | 63,321 (Direct) |
View |
| 2022-01-04 Exercise |
2022-01-06 4:31 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director |
14,270 | $0 | 42,810 (Direct) |
View |
| 2021-12-23 Exercise |
2021-12-28 4:31 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
10,000 | $3.5 | 747,857 (Direct) |
View |
| 2021-12-23 Exercise |
2021-12-28 4:31 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
10,000 | $0 | 747,857 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-23 5:14 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
7,300 | $3.5 | 382,855 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-23 5:14 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
7,300 | $0 | 382,855 (Direct) |
View |
| 2021-12-15 Exercise |
2021-12-17 8:27 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
37,700 | $3.5 | 1,186,327 (Direct) |
View |
| 2021-12-15 Exercise |
2021-12-17 8:27 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
37,700 | $0 | 1,186,327 (Direct) |
View |
| 2021-11-10 Exercise |
2021-11-15 4:18 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
55,000 | $3.5 | 425,875 (Direct) |
View |
| 2021-11-10 Exercise |
2021-11-15 4:18 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
55,000 | $0 | 425,875 (Direct) |
View |
| 2021-09-24 Exercise |
2021-09-28 4:10 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
14,270 | $0 | 676,160 (Direct) |
View |
Ownership |
2021-09-20 5:39 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | PF Equity Holdings 1 B.V. 10% Owner |
0 | $0 | 27,349,211 (Direct) |
View |
| 2021-06-24 Exercise |
2021-06-24 5:32 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Sulzberger Gabrielle Director |
14,270 | $0 | 63,894 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 8:26 pm |
N/A 2031-06-10 |
Cerevel Therapeutics Holdings Inc. | CERE | Gordon Christopher R Director 10% Owner |
42,950 | $0 | 42,950 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 8:25 pm |
N/A 2031-06-10 |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
42,950 | $0 | 42,950 (Direct) |
View |